Kovitz Investment Group Partners
ABBV icon

Kovitz Investment Group Partners’s AbbVie ABBV Stock Holding History

Kovitz Investment Group Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-216
Closed -$463K – 425
2021
Q1 		$463K Buy
216
+33
+18% +$3.53K 0.01% 343
2020
Q4 		$391K Buy
183
+3
+2% +$288 0.01% 351
2020
Q3 		$159K Buy
180
+5
+3% +$471 ﹤0.01% 396
2020
Q2 		$294K Buy
+175
New +$15.4K 0.01% 339

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kovitz Investment Group Partners's ABBV Position: Q1 2026 in Review

Kovitz Investment Group Partners reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $261K and leaving 7,181 shares worth $1.56M. The position accounts for 0.04% of the portfolio, ranked #260.

Kovitz Investment Group Partners first reported a position in ABBV in Q1 2016 and has held it in 41 quarters since. The position peaked at $45.5M in Q3 2025. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Kovitz Investment Group Partners held 7,181 shares of AbbVie worth $1.56M as of Q1 2026.
  • Kovitz Investment Group Partners sold 1,175 AbbVie shares in Q1 2026, an estimated $261K.
  • AbbVie made up 0.04% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #260 holding.
  • Kovitz Investment Group Partners first reported a position in AbbVie in Q1 2016 and has held it in 41 quarters since.
  • Kovitz Investment Group Partners's AbbVie position peaked at $45.5M in Q3 2025.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.